To include your compound in the COVID-19 Resource Center, submit it here.

What Excision needs to demonstrate before bringing CRISPR-HIV therapy to clinic

With mouse data for a functional HIV cure in hand, Excision needs to prove itself in monkeys before entering the clinic next year

After the scientific team behind Excision showed that CRISPR can excise viral HIV DNA from mice genomes, NIAID Director Anthony Fauci cautioned that the therapy will need to prove itself on at least three fronts in non-human primates before it should be tested in humans.

In a Nature Communications paper

Read the full 493 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers